A role of ankyrin-B (ANK2) in cardiac arrhythmias was first evidenced by the identification of a common mutation (E1425G) in patients from a French kindred presenting with atypical LQTS [46], initially referred to as LQT4 and then renamed ankyrin-B syndrome. This evidence concerns the gene ANK2 and cardiac arrhythmia.